Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

Amyloid proteins can clump in tissues and organs, which may affect kidney and heart function. Symptoms can include fatigue, dizziness, and shortness of breath. Buildup in the kidneys can lead to ...

Amyloidosis occurs when a protein called amyloid builds up in organs such as the heart, kidneys, liver, nerves, and digestive system. Deposits may be body-wide or localized and can lead to organ ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...

Amyloidosis is a rare disease that involves the buildup of a specific protein called amyloid. Unlike other proteins, amyloid does not have a supportive role in the body. Instead, the buildup of ...

Please provide your email address to receive an email when new articles are posted on . A new expert consensus decision pathway published by the American College of Cardiology highlights the ...

Amyloidosis is a group of rare disorders caused by deposition of misfolded proteins as insoluble fibrils, which leads to progressive multiorgan failure and death. 1 The past 30 years have seen ...

The first thing to understand about amyloidosis is that it’s not a single disease, but several diseases. Just as the word “cancer” refers to a group of diseases, amyloidosis is the name for a group of ...

Cardiac transthyretin amyloidosis (also called ATTR amyloidosis cardiomyopathy or ATTR-CM) is a progressive disease and a cause of fatal heart failure resulting from extracellular myocardial ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of ...

The National Institutes of Health has classified amyloidosis as a rare condition — one that affects fewer than 200,000 Americans. (1) While most experts who study the disease say it’s presumably much ...

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...